These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 22013730

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P, Petrasova D, Stancak B, Tkacova R.
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H, Yang T, Li D, Wu Y, Zhang X, Pang C, Zhang J, Ying B, Wang T, Wen F.
    Int J Chron Obstruct Pulmon Dis; 2016 Aug; 11():2369-2376. PubMed ID: 27713627
    [Abstract] [Full Text] [Related]

  • 25. Exercise-induced systemic effects in muscle-wasted patients with COPD.
    Van Helvoort HA, Heijdra YF, Thijs HM, Viña J, Wanten GJ, Dekhuijzen PN.
    Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
    Ulubay G, Görek A, Savaş S, Oner Eyüboğlu F.
    Tuberk Toraks; 2005 Sep; 53(4):340-6. PubMed ID: 16456732
    [Abstract] [Full Text] [Related]

  • 28. [Effect of ipratropium bromide on lung dynamic hyperinflation in patients with chronic obstructive lung disease].
    Jorquera J, Díaz O, Lisboa C.
    Rev Med Chil; 2003 Jun; 131(6):605-12. PubMed ID: 12942587
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance?
    Breyer MK, Spruit MA, Celis AP, Rutten EP, Janssen PP, Wouters EF, CIRO Network.
    Clin Nutr; 2009 Dec; 28(6):642-7. PubMed ID: 19540024
    [Abstract] [Full Text] [Related]

  • 32. Systemic inflammation and metabolic syndrome in stable COPD patients.
    Akpınar EE, Akpınar S, Ertek S, Sayın E, Gülhan M.
    Tuberk Toraks; 2012 Dec; 60(3):230-7. PubMed ID: 23030748
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease.
    Tantucci C, Donati P, Nicosia F, Bertella E, Redolfi S, De Vecchi M, Corda L, Grassi V, Zulli R.
    Respir Med; 2008 Apr; 102(4):613-9. PubMed ID: 18083020
    [Abstract] [Full Text] [Related]

  • 35. [The relationship between inflammatory mediators and pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Jiang YW, Pang L, Fang QH, Ma YM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Dec; 34(12):904-8. PubMed ID: 22333502
    [Abstract] [Full Text] [Related]

  • 36. Systemic and airway inflammation and the presence of emphysema in patients with COPD.
    Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, Nikoulis DJ, Georgoulias P, Zakynthinos E, Gourgoulianis KI, Kostikas K.
    Respir Med; 2010 Feb; 104(2):275-82. PubMed ID: 19854037
    [Abstract] [Full Text] [Related]

  • 37. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study.
    Boutou AK, Pitsiou GG, Stanopoulos I, Kontakiotis T, Kyriazis G, Argyropoulou P.
    QJM; 2012 Jul; 105(7):657-63. PubMed ID: 22355163
    [Abstract] [Full Text] [Related]

  • 38. Circulating visfatin in chronic obstructive pulmonary disease.
    Liu X, Ji Y, Chen J, Li S, Luo F.
    Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.